Trend of reduced therapy-related hematologic cancers among patients with three cancer types likely driven by immune modulation, Roswell Park team proposes ...more >
Platform shows its mettle with kidney disease and COVID
Delta 4 announces that encouraging results have been achieved with its drug discovery technology ... more >
Engineers at the Massachusetts Institute of Technology design nanoparticles that stimulate the immune system and help it attack tumors ...more >
Purdue startup gets $2-million SBIR grant to fast-track cancer drug platform technology ...more >
Aqualung Therapeutics receives a $2.3-million award to develop a novel therapeutic antibody for patients with radiation-induced lung injury...more >
ERT survey indicates many companies and organziations are implementing elements of virtual trials due to the pandemic ...more >
Study in California is utilizing IVIG as investigational coronavirus treatment for adults experiencing respiratory failure ...more >
DDN Home | Advertising | Editorial Feedback